David L. Roman, Ph.D.
Affiliations: | 1998-2004 | Medicinal Chemistry and Molecular Pharmacology | Purdue University, West Lafayette, IN, United States |
| 2004-2008 | Pharmacology | University of Michigan Medical School Ann Arbor | |
| 2008- | Pharmaceutical Sciences & Experimental Therapeutics | University of Iowa, Iowa City, IA |
Area:
RGS Proteins, Drug Discovery & HTSGoogle:
"David Roman"Mean distance: 18.19 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Eric L. Barker | grad student | 1998-2004 | Purdue | |
| (Molecular determinants of ligand interaction with serotonin transporters.) | ||||
| Richard Neubig | post-doc | 2004-2008 | University of Michigan Medical School Ann Arbor | |
Children
Sign in to add trainee| Michelle Kroc | research assistant | University of Iowa | |
| Christopher R. Bodle | grad student | University of Iowa | |
| Michael P. Hayes | grad student | University of Iowa | |
| Colin A. Higgins | grad student | University of Iowa | |
| Duncan I. Mackie | grad student | University of Iowa | |
| Joseph B. O'Brien | grad student | University of Iowa | |
| Joshua Wilkinson | grad student | University of Iowa | |
| Carlos A. Monroy | grad student | 2013 | University of Iowa |
| Amrita Roy | post-doc | University of Iowa |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bair A, Printy N, Choi SH, et al. (2024) In Silico Design of Novel RGS2-G Interaction Inhibitors with Anticancer Activity. Journal of Chemical Information and Modeling |
| Wilkinson JC, Lehmler HJ, Roman DL. (2024) High-Throughput GPCRome Screen of Pollutants Reveals the Activity of Polychlorinated Biphenyls at Melatonin and Sphingosine-1-phosphate Receptors. Chemical Research in Toxicology |
| Alexander SPH, Kelly E, Mathie AA, et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets. British Journal of Pharmacology. S1-S22 |
| Dwyer TS, O'Brien JB, Ptak CP, et al. (2022) Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotype. Frontiers in Pharmacology. 13: 977742 |
| Alexander SP, Kelly E, Mathie A, et al. (2021) THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets. British Journal of Pharmacology. 178: S1-S26 |
| O'Brien JB, Roman DL. (2021) Novel treatments for chronic pain: moving beyond opioids. Translational Research : the Journal of Laboratory and Clinical Medicine |
| Hayes MP, O'Brien J, Fowler CA, et al. (2021) Fragment-based nuclear magnetic resonance screen against a Regulator of G Protein Signaling identifies a binding "hot spot". Chembiochem : a European Journal of Chemical Biology |
| Ahlers-Dannen KE, Alqinyah M, Bodle C, et al. (2020) Regulators of G protein Signaling (RGS) proteins (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2020 |
| Ahlers-Dannen KE, Alqinyah M, Bodle C, et al. (2020) Regulators of G protein Signaling (RGS) proteins (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2020 |
| O’Brien J, Hayes M, Watts V, et al. (2020) Approaches to Targeting Adenylyl Cyclase 1 for Novel Pain Therapeutics The Faseb Journal. 34: 1-1 |